Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Ferroportin mutation in autosomal dominant hemochromatosis: loss of function, gain in understanding
Robert E. Fleming, William S. Sly
Robert E. Fleming, William S. Sly
Published August 15, 2001
Citation Information: J Clin Invest. 2001;108(4):521-522. https://doi.org/10.1172/JCI13739.
View: Text | PDF
Commentary

Ferroportin mutation in autosomal dominant hemochromatosis: loss of function, gain in understanding

  • Text
  • PDF
Abstract

Authors

Robert E. Fleming, William S. Sly

×

Total citations by year

Year: 2019 2008 2006 2005 2004 Total
Citations: 1 1 1 1 3 7
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (7)

Title and authors Publication Year
Twenty Years of Ferroportin Disease: A Review or An Update of Published Clinical, Biochemical, Molecular, and Functional Features
LT Vlasveld, R Janssen, E Bardou-Jacquet, H Venselaar, H Hamdi-Roze, H Drakesmith, DW Swinkels
Pharmaceuticals (Basel, Switzerland) 2019
Intracellular iron transport and storage: from molecular mechanisms to health implications
EL MacKenzie, K Iwasaki, Y Tsuji
Antioxidants & Redox Signaling 2008
Analysis of HFE gene mutations and HLA-A alleles in Brazilian patients with iron overload.
Cançado RD, Guglielmi AC, Vergueiro CS, Rolim EG, Figueiredo MS, Chiattone CS
Sao Paulo medical journal = Revista paulista de medicina 2006
Hepcidin in iron overload disorders
G Papanikolaou, M Tzilianos, JI Christakis, D Bogdanos, K Tsimirika, J MacFarlane, YP Goldberg, N Sakellaropoulos, T Ganz, E Nemeth
Blood 2005
Recent advances in understanding haemochromatosis: a transition state
KJ Robson, AT Merryweather-Clarke, E Cadet, V Viprakasit, MG Zaahl, JJ Pointon, DJ Weatherall, J Rochette
Journal of medical genetics 2004
Differences in the uptake of iron from Fe(II) ascorbate and Fe(III) citrate by IEC-6 cells and the involvement of ferroportin/IREG-1/MTP-1/SLC40A1
C Thomas, PS Oates
Pflügers Archiv - European Journal of Physiology 2004
Ferroportin/IREG-1/MTP-1/SLC40A1 modulates the uptake of iron at the apical membrane of enterocytes.
Thomas C, Oates PS
Gut 2004

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts